PDCD1 and pancreatic neoplasm: For example, in mouse model of pancreatic cancer liver metastasis, the group treated with gemcitabine and anti-PD-1 had the lowest average volume of liver metastatic nodules and prolonged survival, compared to gemcitabine alone or anti-PD-1 alone.